Adverum Biotechnologies (ADVM) Announces Upgrade to ADVM-043 Manufacturing Process
Tweet Send to a Friend
Adverum Biotechnologies, Inc. (Nasdaq: ADVM) provided an update on its development program for ADVM-043 (formerly “ANN-001”), a novel gene therapy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
